Lincoln Pharmaceuticals — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Lincoln Pharmaceuticals holds 49.78% of the company. At a market capitalisation of ₹1.01k cr, that holding is worth ₹503 cr.

Promoter stake

49.78%

Value of holding

₹503 cr

Market cap

₹1.01k cr

Stake change

+14.81%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q4-2015
34.97%—
Q1-2016
34.93%—
Q2-2016
34.93%—
Q3-2016
34.91%—
Q4-2016
32.47%—
Q1-2017
32.46%—
Q2-2017
32.46%—
Q3-2017
32.47%—
Q4-2017
32.72%—
Q1-2018
31.43%—
Q2-2018
31.68%—
Q3-2018
31.68%—
Q4-2018
31.68%—
Q1-2019
31.68%—
Q2-2019
31.68%—
Q3-2019
31.68%—
Q4-2019
31.68%—
Q1-2020
31.63%—
Q2-2020
31.63%—
Q3-2020
31.68%—
Q4-2020
32.68%—
Q1-2021
37.26%—
Q2-2021
37.06%—
Q3-2021
39.55%—
Q4-2021
41.28%—
Q1-2022
41.32%—
Q2-2022
43.36%—
Q3-2022
43.36%—
Q4-2022
45.61%—
Q1-2023
46.28%—
Q2-2023
47.95%—
Q3-2023
49.80%—
Q4-2023
49.80%—
Q1-2024
49.53%—
Q2-2024
49.78%—
Q3-2024
49.78%—
Q4-2024
49.78%—
Q1-2025
49.78%—
Q2-2025
49.78%—
Q3-2025
49.78%—
Q4-2025
49.78%—
Q1-2026
49.78%—
Q2-2026
49.78%—
Q3-2026
49.78%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Lincoln Pharmaceuticals's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.